Literature DB >> 7613408

Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic.

M Hanif1, M R Mobarak, A Ronan, D Rahman, J J Donovan, M L Bennish.   

Abstract

OBJECTIVE: To determine the cause of a large increase in the number of children with unexplained renal failure.
DESIGN: Case-control study.
SETTING: Children's hospital in Dhaka, Bangladesh.
SUBJECTS: Cases were all 339 children with initially unexplained renal failure; controls were 90 children with cause of renal failure identified; all were admitted to hospital during 35 months after January 1990. MAIN OUTCOME MEASURES: Differences between the case and control patients in clinical and histological features and outcome; toxicological examination of 69 bottles of paracetamol from patients and pharmacies.
RESULTS: Compared with children with an identified cause for their renal failure, children with initially unexplained renal failure were significantly (P < 0.05) more likely to have hepatomegaly (58% v 33%), oedema (37% v 20%), and hypertension (58% v 23%); to have a higher serum creatinine concentration (mean 519 mumol/l v 347 mumol/l) and lower serum bicarbonate concentration (10.1 mmol/l v 12.4 mmol/l); to have been given a drug for fever (91% v 31%); to have ingested a brand of paracetamol shown to contain diethylene glycol (20% v 0%); and to have died in hospital (70% v 33%). Diethylene glycol was identified in 19 bottles of paracetamol, from 7 of 28 brands tested. In the 12 months after a government ban on the sale of paracetamol elixir, new cases of renal failure decreased by 54%, and cases of unexplained renal failure decreased by 84%.
CONCLUSION: Paracetamol elixirs with diethylene glycol as a diluent were responsible for a large outbreak of fatal renal failure in Bangladesh.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613408      PMCID: PMC2550149          DOI: 10.1136/bmj.311.6997.88

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Bangladesh pharmaceutical policy and politics.

Authors:  M R Reich
Journal:  Health Policy Plan       Date:  1994-06       Impact factor: 3.344

2.  Acute intoxication due to topical application of diethylene glycol.

Authors:  M C Cantarell; J Fort; J Camps; M Sans; L Piera
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

3.  [A patient with acute tubular necrosis as a consequence of drinking diethylene glycol-treated wine].

Authors:  R van Leusen; D R Uges
Journal:  Ned Tijdschr Geneeskd       Date:  1987-05-02

4.  Letter from Bombay. An unmitigated tragedy.

Authors:  S K Pandya
Journal:  BMJ       Date:  1988-07-09

5.  Diethylene glycol poisoning in children.

Authors:  M D Bowie; D McKenzie
Journal:  S Afr Med J       Date:  1972-07-01

6.  [Medical sequelae of the contamination of wine with diethylene glycol].

Authors:  P M van der Linden-Cremers; B Sangster
Journal:  Ned Tijdschr Geneeskd       Date:  1985-09-28

7.  Diethylene glycol poisoning in Nigerian children.

Authors:  H O Okuonghae; I S Ighogboja; J O Lawson; E J Nwana
Journal:  Ann Trop Paediatr       Date:  1992

8.  Stroke rehabilitation: Australian patient profile and functional outcome.

Authors:  S Shah; F Vanclay; B Cooper
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

  8 in total
  27 in total

1.  Diethylene glycol deaths in Haiti.

Authors:  S W Junod
Journal:  Public Health Rep       Date:  2000 Jan-Feb       Impact factor: 2.792

2.  Counterfeit medicines in Cambodia--possible causes.

Authors:  Mohiuddin Hussain Khan; Junko Okumura; Tey Sovannarith; Nam Nivanna; Hiroto Nagai; Masatoshi Taga; Naoko Yoshida; Manabu Akazawa; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  Pharm Res       Date:  2010-10-01       Impact factor: 4.200

3.  The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999.

Authors:  Lamphone Syhakhang; Cecilia Stålsby Lundborg; Björn Lindgren; Göran Tomson
Journal:  Pharm World Sci       Date:  2004-12

Review 4.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Diagnosing renal failure due to diethylene glycol in children in a resource-constrained setting.

Authors:  Rosamund Modupe Akuse; Felicia Uchezuba Eke; Adebowale Dele Ademola; Iretiola Bamikeolu Fajolu; Henry Olusegun Gbelee; Ugochi Ihejiahi; Mairo Adamu Bugaje; Ifoema Comfort Anochie; Adanze Onyenonachi Asinobi; Henrietta Uchenna Okafor; Solomon Ibiyemi Adeleke; Lamidi Isah Audu; Adekunle Otuneye; Elizabeth Disu; Hafsat Idris; Henry Aikhonbare; Alhassan Yakubu; William Ogala; Olufemi Ogunrinde; Robinson Wammanda; Adeola Orogade; Jane Anyiam; Edwin Eseigbe; Lawal Umar; Hafsat Musa; Richard Onalo; Boma West; Nsirimobu Paul; Folusho Lesi; Taiwo Ladapo; Ojombo Boyede; Rahmon Okeowo; Akeem Mustapha; Ibironke Akinola; Oma Chima-Oduko; Olugbenga Awobusuyi
Journal:  Pediatr Nephrol       Date:  2012-01-15       Impact factor: 3.714

Review 6.  Improving drug use for children in the developing world.

Authors:  S A Beggs; N E Cranswick; M D Reed
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

7.  Other factors may have contributed to epidemic of renal failure.

Authors:  M Hossain
Journal:  BMJ       Date:  1995-10-07

8.  Venous diethylene glycol poisoning in patients with preexisting severe liver disease in China.

Authors:  Bing-Liang Lin; Zhi-Xin Zhao; Yu-Tian Chong; Jian-Guo Li; Xing Zuo; Yu Tao; Tan-Qi Lou; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

9.  Outbreak of acute renal failure in Panama in 2006: a case-control study.

Authors:  E Danielle Rentz; Lauren Lewis; Oscar J Mujica; Dana B Barr; Joshua G Schier; Gayanga Weerasekera; Peter Kuklenyik; Michael McGeehin; John Osterloh; Jacob Wamsley; Washington Lum; Camilo Alleyne; Nestor Sosa; Jorge Motta; Carol Rubin
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

10.  Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers.

Authors:  Habibat A Garuba; Jillian C Kohler; Anna M Huisman
Journal:  Global Health       Date:  2009-10-29       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.